The Impact of COVID-19 on the Health Insurance Industry

Summary

Our panel of experts engaged in an in-depth discussion of the rapidly evolving regulatory environment surrounding COVID-19 testing and treatment and the strategic, financial, and operational challenges this disease presents for health insurers.

Please note: This is an archived post. Some of the information and data discussed in this article may be out of date. It is preserved here for historical reference but should not be used as the basis for business decisions. Please see our main Insights section for more recent posts.

Access Recording

As COVID-19 creates unprecedented challenges for the US healthcare system, health plan leaders must adapt quickly to a transformed health insurance landscape while keeping an eye on normal business requirements to ensure they are prepared for a post-COVID-19 world.

Our panel of experts held an in-depth discussion of the rapidly evolving regulatory environment surrounding COVID-19 testing and treatment and the strategic, financial, and operational challenges this disease presents for health insurers. Our panelists explored the regulatory and legislative changes that are transforming the Medicare Advantage program, including the final 2021 Rate Announcement, along with the potential impacts of the 2020 election on the health insurance industry.

Key topics included:

COVID-19 regulatory environment and challenges
Medicare Advantage developments and 2021 Rate Announcement
2020 election impacts on the health insurance industry

Panelists

Moderator

Fred Bentley , Managing Director, Center for Healthcare Transformation

Fred Bentley advises clients on health delivery and payment innovation, providing analytic and strategic insight on issues related to the delivery of care.

Speaker

Michael Lutz , Managing Director, Evidence & Strategy

Michael Lutz applies his background in plan strategy and operations to help clients anticipate changes in state and federal regulations and ensure compliance across all lines of business.

Speaker

Matt Kazan , Managing Director, Policy

Matt Kazan advises health plans, life sciences clients, and patient organizations as they navigate the policy landscape, focusing on Medicare Part D and Medicare Advantage, and implementation of the Inflation Reduction Act.